Cagent Vascular

Wayne, PA · Founded 2014 · Privately Held (backing)

Developer of an intravascular technology designed to treat diseased peripheral arteries. Cagent Vascular is based in Wayne, PA and was founded in 2014. Its last reported valuation was $80.7 million in Jan 2024. It has raised $73.2 million across 5 recorded rounds; the latest was a $24.5 million early-stage round in May 2026.

Last reported valuation
$80.7M
Oct 2026
Priced at
—
Total raised
$73.2M
Last round
Early Stage VC
May 2026
What is Cagent Vascular worth?
$80.7Mlast reported valuation · Oct 2026

Cagent Vascular's last reported valuation, Jan 2024. Nothing priced has surfaced since.

Free account
More of Cagent Vascular with a free account
  • ·Watch Cagent Vascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Cagent Vascular funding history

5 rounds
DateRoundRaisedPost-money
May 2026Early Stage VC$24.5M▮
Jan 2024Early Stage VC$28.7M▮
Apr 2023Debt$7.2M▮
Jun 2021Early Stage VC$9.5M▮
Jul 2017Seed Round$3.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Cagent Vascular valuation

Cagent Vascular's last reported valuation was $80.7 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Cagent Vascular raised?

Cagent Vascular has raised $73.2 million across 5 recorded rounds since 2017. The largest was a $9.5 million early-stage round in Jun 2021; the most recent was a $24.5 million early-stage round in May 2026.

Cagent Vascular has filed 7 Form Ds with the SEC since 2014, most recently in Jun 2026 ($24.5 million sold to 51 investors).

How Cagent Vascular's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cagent Vascular, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Cagent Vascular

What is Cagent Vascular worth?
Cagent Vascular is valued at $80.7M as of Oct 2026. Cagent Vascular's last reported valuation, Jan 2024. Nothing priced has surfaced since.
How much has Cagent Vascular raised?
Cagent Vascular has raised $73.2M in total funding across 5 recorded rounds.
When did Cagent Vascular last raise?
Cagent Vascular last raised in May 2026 (Early Stage VC), raising $24.5M.